Dual Incretin Agonists Emerge as Promising Adjunctive Therapy for Obesity in Type 1 Diabetes
A clinical perspective in Frontiers in Endocrinology details how adjunctive incretin receptor agonists can improve glycemic control, promote weight loss, ...




















